The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1020658212 10206582 12 F 20141109 20160920 20140530 20160926 EXP US-GLAXOSMITHKLINE-A1045256A GLAXOSMITHKLINE 37.70 YR F Y 0.00000 20160926 OT COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1020658212 10206582 1 PS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) CONCENTRATION 120,000 NG/ML, PUMP RATE 83 ML/DAY, VIAL STRENGTH 1.5 MG U P508 20444 115 DF POWDER FOR INFUSION
1020658212 10206582 2 SS FLOLAN EPOPROSTENOL SODIUM 1 118 NG/KG/MIN U T366 20444 POWDER FOR INFUSION
1020658212 10206582 3 SS FLOLAN EPOPROSTENOL SODIUM 1 118NG/KG/MIN U T794 20444 POWDER FOR INFUSION
1020658212 10206582 4 SS FLOLAN EPOPROSTENOL SODIUM 1 UNK, CO U V049 20444 POWDER FOR INFUSION
1020658212 10206582 5 SS FLOLAN EPOPROSTENOL SODIUM 1 118 NG/KG/MIN, CO U UNKNOWN 20444 POWDER FOR INFUSION
1020658212 10206582 6 SS FLOLAN EPOPROSTENOL SODIUM 1 118 NG/KG/MIN, CONTINUOUSLY U Z111 20444 118 DF POWDER FOR INFUSION
1020658212 10206582 7 SS FLOLAN EPOPROSTENOL SODIUM 1 118 NG/KG/MIN, CONTINUOUSLY U Z880 20444 118 DF POWDER FOR INFUSION
1020658212 10206582 8 SS FLOLAN EPOPROSTENOL SODIUM 1 116 NG/KG/MIN, CO U C769109 20444 POWDER FOR INFUSION
1020658212 10206582 9 SS FLOLAN EPOPROSTENOL SODIUM 1 Intravenous (not otherwise specified) 116 NG/KG/MIN, CO U J171 20444 116 DF POWDER FOR INFUSION
1020658212 10206582 10 SS FLOLAN EPOPROSTENOL SODIUM 1 U C769109 0 SOLUTION FOR INJECTION
1020658212 10206582 11 C TRACLEER BOSENTAN 1 U 0
1020658212 10206582 12 C REVATIO SILDENAFIL CITRATE 1 U 0
1020658212 10206582 13 C COUMADIN WARFARIN SODIUM 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1020658212 10206582 1 Pulmonary arterial hypertension
1020658212 10206582 10 Pulmonary arterial hypertension

Outcome of event

Event ID CASEID OUTC COD
1020658212 10206582 HO
1020658212 10206582 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1020658212 10206582 Cough
1020658212 10206582 Device alarm issue
1020658212 10206582 Device infusion issue
1020658212 10206582 Device leakage
1020658212 10206582 Device related infection
1020658212 10206582 Diarrhoea
1020658212 10206582 Dyspnoea
1020658212 10206582 Emergency care
1020658212 10206582 Haematemesis
1020658212 10206582 Haemoptysis
1020658212 10206582 Hospitalisation
1020658212 10206582 Ill-defined disorder
1020658212 10206582 Malaise
1020658212 10206582 Nausea
1020658212 10206582 Pallor
1020658212 10206582 Thrombosis
1020658212 10206582 Vascular injury
1020658212 10206582 Volume blood decreased
1020658212 10206582 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1020658212 10206582 1 20090410 0
1020658212 10206582 5 20111021 0
1020658212 10206582 6 20111021 0
1020658212 10206582 7 20111021 0
1020658212 10206582 8 20111021 0